ARHGAP11A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.052600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.846400E-01
Normal-vs-Stage2
2.724600E-01
Normal-vs-Stage3
9.123200E-01
Normal-vs-Stage4
4.728800E-01
Stage1-vs-Stage2
6.219400E-01
Stage1-vs-Stage3
4.496000E-01
Stage1-vs-Stage4
9.348800E-01
Stage2-vs-Stage3
2.363200E-01
Stage2-vs-Stage4
6.191200E-01
Stage3-vs-Stage4
4.255800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.938200E-01
Normal-vs-AfricanAmerican
6.923400E-01
Normal-vs-Asian
4.319200E-01
Caucasian-vs-AfricanAmerican
2.768800E-01
Caucasian-vs-Asian
6.117700E-02
AfricanAmerican-vs-Asian
6.876000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.264800E-01
Normal-vs-Female
2.883400E-01
Male-vs-Female
4.563400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.660400E-01
Normal-vs-Age(41-60Yrs)
2.621400E-01
Normal-vs-Age(61-80Yrs)
3.314000E-01
Normal-vs-Age(81-100Yrs)
3.194000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.747400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.741400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.356000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.187810E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.302800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.375200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.914200E-01
Normal-vs-Daily Drinker
4.505800E-01
Normal-vs-Weekly Drinker
4.079200E-01
Normal-vs-Occasional Drinker
2.738400E-01
Normal-vs-Social Drinker
2.349200E-01
Non Drinker-vs-Daily Drinker
7.806000E-01
Non Drinker-vs-Weekly Drinker
5.945600E-01
Non Drinker-vs-Occasional Drinker
6.724200E-01
Non Drinker-vs-Social Drinker
9.686800E-01
Daily Drinker-vs-Weekly Drinker
8.176200E-01
Daily Drinker-vs-Occasional Drinker
9.286800E-01
Daily Drinker-vs-Social Drinker
8.129200E-01
Weekly Drinker-vs-Occasional Drinker
8.589800E-01
Weekly Drinker-vs-Social Drinker
6.555400E-01
Occasional Drinker-vs-Social Drinker
7.010200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.228200E-01
Normal-vs-Grade 2
7.064200E-01
Normal-vs-Grade 3
7.590800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.424400E-03
Grade 1-vs-Grade 3
2.046500E-04
Grade 1-vs-Grade 4
6.228200E-01
Grade 2-vs-Grade 3
1.219620E-01
Grade 2-vs-Grade 4
7.064200E-01
Grade 3-vs-Grade 4
7.590800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.383400E-01
Normal-vs-NonDiabetic
2.752400E-01
Diabetic-vs-NonDiabetic
2.018600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.113640E-01
Normal-vs-NoPancreatitis
3.358200E-01
Pancreatitis-vs-NoPancreatitis
9.842400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.029000E-01
Normal-vs-N1
2.779800E-01
N0-vs-N1
1.252040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.712200E-02
Normal-vs-TP53-NonMutant
3.501600E-01
TP53-Mutant-vs-TP53-NonMutant
4.23549999994943E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
